Minimal residual disease (MRD) in Waldenström macroglobulinaemia (WM): Impact on survival outcomes with rituximab-based therapies.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2019)
关键词
Flow Cytometry,Minimal residual disease,Waldenstrom macroglobulinemia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要